Results 11 to 20 of about 2,734 (187)

Insights into the molecular basis of the palmitoylation and depalmitoylation of NCX1 [PDF]

open access: yesCell Calcium, 2021
Catalyzed by zDHHC-PAT enzymes and reversed by thioesterases, protein palmitoylation is the only post-translational modification recognized to regulate the sodium/calcium exchanger NCX1. NCX1 palmitoylation occurs at a single site at position 739 in its large regulatory intracellular loop.
Caglar Gök   +8 more
openaire   +8 more sources

Palmitoylation: an emerging therapeutic target bridging physiology and disease [PDF]

open access: yesCellular & Molecular Biology Letters
Palmitoylation is a reversible post-translational lipid modification of proteins, catalyzed by the Zinc finger DHHC domain-containing (ZDHHC) family of palmitoyltransferases.
Weini Li   +7 more
doaj   +2 more sources

Glutathione-dependent depalmitoylation of phospholemman by peroxiredoxin 6

open access: yesCell Reports
Summary: Phospholemman (PLM) regulates the cardiac sodium pump: PLM phosphorylation activates the pump whereas PLM palmitoylation inhibits its activity.
Jacqueline Howie   +11 more
doaj   +4 more sources

Inhibition of BRD4 sensitizes NSCLC cells to osimertinib by suppressing APT1 and promoting MST1 palmitoylation [PDF]

open access: yesCell Death Discovery
Osimertinib is widely used to treat non-small-cell lung cancer (NSCLC) carrying epidermal growth factor receptor (EGFR) mutations. However, osimertinib resistance inevitably develops in almost all patients.
Shaoqiang Wang   +5 more
doaj   +2 more sources

Dual Regulation of Sprouty 4 Palmitoylation by ZDHHC7 and Palmitoyl-Protein Thioesterase 1: A Potential Therapeutic Strategy for Cisplatin-Resistant Osteosarcoma [PDF]

open access: yesResearch
Background: Osteosarcoma (OS) is a primary malignant bone tumor predominantly affecting adolescents. Chemotherapeutic agents, such as cisplatin, are commonly used in OS treatment; however, drug resistance markedly undermines treatment efficacy and ...
Tianlong Huang   +9 more
doaj   +2 more sources

Protein S-Palmitoylation as Potential Therapeutic Target for Dermatoses [PDF]

open access: yesBiomolecules
Protein S-palmitoylation is a pivotal yet poorly integrated research field in dermatology. This reversible post-translational lipid modification primarily occurs on cysteine residues and is principally catalyzed by zinc finger and Asp-His-His-Cys DHHC ...
Yanhai Feng   +9 more
doaj   +2 more sources

ABHD7-mediated depalmitoylation of lamin A promotes myoblast differentiation

open access: yesCell Reports
Summary: LMNA gene mutation can cause muscular dystrophy, and post-translational modification plays a critical role in regulating its function. Here, we identify that lamin A is palmitoylated at cysteine 522, 588, and 591 residues, which are reversely ...
Yuan Shen   +10 more
doaj   +3 more sources

Engineered depalmitoylases enable selective manipulation of protein localization and function [PDF]

open access: yesNature Communications
S-Palmitoylation is a reversible post-translational modification that tunes the localization, stability, and function of an impressive array of proteins including ion channels, G-proteins, and synaptic proteins.
Srinidhi Jayaraman   +4 more
doaj   +2 more sources

The Unconventional Role of ABHD17A in Increasing the S-Palmitoylation and Antiviral Activity of IFITM1 by Downregulating ABHD16A [PDF]

open access: yesBiomolecules
The broad-spectrum antiviral functions of interferon-inducible transmembrane 1 (IFITM1) rely on S-palmitoylation post-translational modification.
Xuemeng Shi   +11 more
doaj   +2 more sources

Swine RNF5 positively regulates the antiviral activity of IFITM1 by mediating the degradation of ABHD16A [PDF]

open access: yesJournal of Virology
Interferon-inducible transmembrane (IFITM) proteins are broad-spectrum antiviral factors that confer cellular resistance to virus invasion. α/β-Hydrolase domain-containing 16A (ABHD16A) has recently been identified as a novel depalmitoylase that can ...
Xuemeng Shi   +10 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy